ClinicalBiostats

Clinical Trials

See the methods at work.

Statistical analyses of real clinical trials: design, endpoints, results and interpretation, organized by therapeutic area and linked to the methods behind them.

6,287 trials analyzed so far

Trials that use: Wilcoxon / Mann-Whitney test

New to this method? Read the tutorial →

77 results

Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.: Complete Statistical AnalysisIndependent statistical analysis of Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04871815).Phase 2/3Results postedn = 22NCT04871815
Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02): Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02): primary endpoint results, effect estimate…Phase 3Results postedn = 49NCT01438840
Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE): Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 91NCT00262080
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03194698).Phase NAResults postedn = 20NCT03194698
Efficacy of Shinabro in Hand Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Shinabro in Hand Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01910116).Phase 2/3Results postedn = 220NCT01910116
Elucidation of Acid-Induced Pulmonary Inflammation: Complete Statistical AnalysisIndependent statistical analysis of Elucidation of Acid-Induced Pulmonary Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00361972).Phase 2/3Results postedn = 17NCT00361972
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 122NCT00474903
Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 118NCT03600818
Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 44NCT01626989
EVOLVEIIIndependent statistical analysis of Epanova® for Lowering Very High Triglycerides II (EVOLVE II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02009865).Phase 3Results postedn = 379NCT02009865
FAPESTIndependent statistical analysis of A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 92NCT01187901
Flumazenil for the Treatment of Primary Hypersomnia: Complete Statistical AnalysisIndependent statistical analysis of Flumazenil for the Treatment of Primary Hypersomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01183312).Phase 1/2Results postedn = 10NCT01183312
Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients: Complete Statistical AnalysisIndependent statistical analysis of Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 8NCT01359735
MANDALAA detailed statistical analysis of the phase 3 MANDALA trial of budesonide/albuterol metered-dose inhalers versus albuterol in adults and children 4 years of age or older with asthma, including time-to-event, rate, binary,…Phase 3Results postedn = 3,132NCT03769090
Mona LisaIndependent statistical analysis of Clinical Evaluation of the GLYDe Dressing for Post-surgical Incision Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00766727).Phase NAResults postedn = 12NCT00766727
PATENT-1Independent statistical analysis of PATENT-1, a randomized phase 3 trial of oral riociguat in patients with pulmonary arterial hypertension, covering its 6-minute walking distance endpoint, ANCOVA, nonparametric and stratified analyses, secondary outcomes,…Phase 3Results postedn = 445NCT00810693
PlaceboIndependent statistical analysis of Efficacy of Open Label Placebo in Children With FGIDs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02389998).Phase NAResults postedn = 31NCT02389998
ProFEIBAIndependent statistical analysis of Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2/3Results postedn = 34NCT00221195
PRONTO-PumpIndependent statistical analysis of A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes: primary endpoint results, effect estimate with…Phase 3Results postedn = 49NCT03433677
RELAX-AHF-2Independent statistical analysis of Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 6,600NCT01870778
RELAX-AHF-EUComplete statistical analysis of RELAX-AHF-EU, a randomized phase 3 trial evaluating serelaxin plus standard of care versus standard of care in patients with acute heart failure, including time-to-event, categorical, continuous, and longitudinal…Phase 3Results postedn = 2,666NCT02064868
RELAX-AHF-EUIndependent statistical analysis of Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 2,666NCT02064868
SINGLEComplete statistical analysis of the SINGLE phase 3 trial comparing dolutegravir plus abacavir/lamivudine with Atripla in HIV-1 infection, including the Week 48 primary endpoint, later virologic suppression analyses, CD4 outcomes, non-inferiority methodology,…Phase 3Results postedn = 844NCT01263015
SNOCATIndependent statistical analysis of SNOCAT, a randomized phase 2/3 trial of sodium nitrite versus placebo for out-of-hospital cardiac arrest, including primary survival results, secondary endpoints, statistical methods, and interpretation.Phase 2/3Results postedn = 1,502NCT03452917
SUPPORTIndependent statistical analysis of A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 174NCT01874262
TRANSFORM-HFComplete statistical analysis of TRANSFORM-HF, the randomized phase 3 comparison of torsemide versus furosemide for management of heart failure, including time-to-event, rehospitalization, quality-of-life, and depression analyses.Phase 3Results postedn = 2,973NCT03296813
ZoMARSIndependent statistical analysis of Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 48NCT01348269